# Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section

> **NCT07511491** · NA · RECRUITING · sponsor: **Tanta University** · enrollment: 90 (estimated)

## Conditions studied

- Ondansetron
- Lozenge
- Intravenous
- Prevention
- Shivering
- Cesarean Section

## Interventions

- **DRUG:** Ondansetron lozenge
- **DRUG:** Ondansetron intravenous

## Key facts

- **NCT ID:** NCT07511491
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-11
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511491, "Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07511491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*